{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:25:39Z","timestamp":1792200339424,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.14283\/jpad.2023.99","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T09:34:42Z","timestamp":1692783282000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults"],"prefix":"10.1016","volume":"11","author":[{"given":"A.","family":"Sadlon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Takousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Prokopenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-M.","family":"Udeh-Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2023.99_bib1","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"4","key":"10.14283\/jpad.2023.99_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementi","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nature medicine"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib4","doi-asserted-by":"crossref","first-page":"fcad057","DOI":"10.1093\/braincomms\/fcad057","article-title":"Plasma phosphorylated tau 217 in preclinical Alzheimer's disease","volume":"5","author":"Jonaitis","year":"2023","journal-title":"Brain Communications"},{"issue":"11","key":"10.14283\/jpad.2023.99_bib5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","article-title":"Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal flui","volume":"15","author":"Takousis","year":"2019","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-160835","article-title":"MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease","volume":"55","author":"Lusardi","year":"2017","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"11","key":"10.14283\/jpad.2023.99_bib7","doi-asserted-by":"crossref","first-page":"e13659","DOI":"10.15252\/emmm.202013659","article-title":"A microRNA signature that correlates with cognition and is a target against cognitive declin","volume":"13","author":"Islam","year":"2021","journal-title":"EMBO molecular medicine"},{"key":"10.14283\/jpad.2023.99_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-6-26","article-title":"Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels","volume":"6","author":"Campos-Melo","year":"2013","journal-title":"Molecular brain"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseas","volume":"25","author":"Preische","year":"2019","journal-title":"Nature medicine"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib10","first-page":"2373","article-title":"MicroRNA-125b regulates Alzheimer's disease through SphK1 regulation","volume":"18","author":"Jin","year":"2018","journal-title":"Mol Med Rep"},{"issue":"5746","key":"10.14283\/jpad.2023.99_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1126\/science.1116502","article-title":"Sequence variants in SLITRK1 are associated with Tourette's syndrom","volume":"310","author":"Abelson","year":"2005","journal-title":"Science (New York, NY)"},{"key":"10.14283\/jpad.2023.99_bib12","author":"Moraghebi"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib13","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.3892\/mmr.2015.3968","article-title":"A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's diseas","volume":"12","author":"Zhang","year":"2015","journal-title":"Molecular medicine reports"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","article-title":"TLR2 is a primary receptor for Alzheimer's amyloid \u03b2 peptide to trigger neuroinflammatory activati","volume":"188","author":"Liu","year":"2012","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.14283\/jpad.2023.99_bib15","author":"Chopra"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.14283\/jpad.2023.99_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14283\/jpad.2019.31","article-title":"Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study","volume":"6","author":"Udeh-Momoh","year":"2019","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.99_bib20","series-title":"Rbans repeatable battery for the assessment of neuropsychological status: Manual","author":"Randolph","year":"1999"},{"issue":"8","key":"10.14283\/jpad.2023.99_bib21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/arclin\/act057","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's diseas","volume":"28","author":"Karantzoulis","year":"2013","journal-title":"Archives of clinical neuropsychology: the official journal of the National Academy of Neuropsychologists"},{"issue":"5","key":"10.14283\/jpad.2023.99_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.acn.2008.06.004","article-title":"Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive power","volume":"23","author":"Duff","year":"2008","journal-title":"Archives of clinical neuropsychology: the official journal of the National Academy of Neuropsychologists"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gpb.2015.02.004","article-title":"Regulatory MicroRNA Networks: Complex Patterns of Target Pathways for Disease-related and Housekeeping MicroRNAs","volume":"13","author":"Zafari","year":"2015","journal-title":"Genomics, Proteomics & Bioinformatics"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib24","doi-asserted-by":"crossref","first-page":"e0193173","DOI":"10.1371\/journal.pone.0193173","article-title":"MicroRNA profiling in plasma samples using qPCR arrays: Recommendations for correct analysis and interpretation","volume":"13","author":"Gevaert","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"10.14283\/jpad.2023.99_bib25","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/nprot.2010.116","article-title":"Data quality control in genetic case-control association studies","volume":"5","author":"Anderson","year":"2010","journal-title":"Nat Protoc"},{"issue":"7845","key":"10.14283\/jpad.2023.99_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.14283\/jpad.2023.99_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"5","key":"10.14283\/jpad.2023.99_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.14283\/jpad.2023.99_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","article-title":"Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subject","volume":"41","author":"Wu","year":"2008","journal-title":"Clinical biochemistry"},{"issue":"4","key":"10.14283\/jpad.2023.99_bib30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3233\/JAD-191120","article-title":"Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid","volume":"73","author":"Rauchmann","year":"2020","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap","volume":"14","author":"Reimand","year":"2019","journal-title":"Nat Protoc"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pro.3987","article-title":"The Human Protein Atlas-Spatial localization of the human proteome in health and diseas","volume":"30","author":"Digre","year":"2021","journal-title":"Protein science: a publication of the Protein Society"},{"issue":"5","key":"10.14283\/jpad.2023.99_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527312666131223113900","article-title":"Wnt\/\u03b2-catenin signaling in Alzheimer's disease","volume":"13","author":"De Ferrari","year":"2014","journal-title":"CNS & neurological disorders drug targets"},{"issue":"2","key":"10.14283\/jpad.2023.99_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1096\/fj.14-253211","article-title":"Activation of the Wnt\/ \u03b2-catenin pathway represses the transcription of the \u03b2-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promote","volume":"29","author":"Parr","year":"2015","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2012.03.045","article-title":"MicroRNA-26a promotes cholangiocarcinoma growth by activating \u03b2-cateni","volume":"143","author":"Zhang","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003160.pub3","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2016","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.14283\/jpad.2023.99_bib37","doi-asserted-by":"crossref","first-page":"577362","DOI":"10.1016\/j.jneuroim.2020.577362","article-title":"Toll-like receptors in Alzheimer's disease","volume":"348","author":"Momtazmanesh","year":"2020","journal-title":"Journal of Neuroimmunology"},{"key":"10.14283\/jpad.2023.99_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-122131","article-title":"\u03b2CTF-Correlated Burst of Hippocampal TNF\u03b1 Occurs at a Very Early, Pre-Plaque Stage in the TgCRND8 Mouse Model of Alzheimer's Disease","volume":"36","author":"Cavanagh","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib39","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nature Communications"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib40","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/s41467-020-18405-9","article-title":"Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging","volume":"11","author":"Flores","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1440-1681.13212","article-title":"MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1","volume":"47","author":"Wang","year":"2020","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"10.14283\/jpad.2023.99_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajpath.2013.10.002","article-title":"High activities of BACE1 in brains with mild cognitive impairmen","volume":"184","author":"Cheng","year":"2014","journal-title":"The American journal of pathology"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib43","first-page":"792","article-title":"An early and late peak in microglial activation in Alzheimer's disease trajector","volume":"140","author":"Fan","year":"2017","journal-title":"Brain: a journal of neurology"},{"key":"10.14283\/jpad.2023.99_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-2-22","article-title":"Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice","volume":"2","author":"Heneka","year":"2005","journal-title":"Journal of neuroinflammation"},{"issue":"17","key":"10.14283\/jpad.2023.99_bib45","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1523\/JNEUROSCI.2262-14.2015","article-title":"Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mic","volume":"35","author":"Thakker","year":"2015","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"10.14283\/jpad.2023.99_bib46","author":"Hampel"},{"issue":"3","key":"10.14283\/jpad.2023.99_bib47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/med.21637","article-title":"Targeting MDM2 for novel molecular therapy: Beyond oncolog","volume":"40","author":"Wang","year":"2020","journal-title":"Medicinal research reviews"},{"issue":"336","key":"10.14283\/jpad.2023.99_bib48","doi-asserted-by":"crossref","first-page":"336ra61","DOI":"10.1126\/scitranslmed.aad9370","article-title":"MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrom","volume":"8","author":"Li","year":"2016","journal-title":"Science translational medicine"},{"issue":"6","key":"10.14283\/jpad.2023.99_bib49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/13854046.2020.1807058","article-title":"Validation of one-year reliable change in the RBANS for community-dwelling older adults with amnestic mild cognitive impairment","volume":"36","author":"Hammers","year":"2022","journal-title":"Clin Neuropsychol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:09:19Z","timestamp":1737338959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2274580724001274"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.99","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.99","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}